Lemme is a Consumer Longevity company founded in 2022 and based in New York, United States.
No dated funding rounds on file. This company is privately held and may be raising or operating on undisclosed capital.
No articles ingested yet for Lemme. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
A vaginal probiotic gummy marketed as the top-selling vaginal probiotic gummy in the U.S. It is designed to support women's intimate and vaginal microbiome health in a daily, easy-to-take gummy format. Lemme positions it within its broader women's wellness line, which emphasizes clinically studied ingredients, non-GMO formulation, and a flavor-forward experience that makes daily supplementation feel routine rather than clinical.
An award-winning magnesium and melatonin sleep gummy for adults seeking help falling asleep and staying rested. It combines magnesium with melatonin in a chewable format intended to fit into an evening routine without pills or capsules. Lemme markets it as part of a women's wellness portfolio built on science-backed ingredients and transparent labeling, with no parabens or silicon dioxide in the formula.
A daily probiotic digestive gummy formulated to help relieve bloating and support gut comfort. It is one of the brand's best-selling products and targets a common everyday concern for women with a convenient gummy format. Lemme differentiates it through clinically studied probiotic and digestive ingredients, positioning it alongside other gut-health SKUs such as Lemme No. 2, a daily fiber and probiotic gummy launched in 2025.